|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|May 24, 2022||referred to insurance|
delivered to assembly
|May 23, 2022||ordered to third reading cal.1440|
committee discharged and committed to rules
|Feb 01, 2022||referred to insurance|
senate Bill S8191
Archive: Last Bill Status - Passed Senate
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S8191 (ACTIVE) - Details
S8191 (ACTIVE) - Summary
Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.
S8191 (ACTIVE) - Sponsor Memo
BILL NUMBER: S8191 SPONSOR: BRESLIN TITLE OF BILL: An act to amend the insurance law and the public health law, in relation to requiring a utilization review agent to follow certain rules when establishing a step therapy protocol PURPOSE OR GENERAL IDEA OF BILL: The purpose of this bill is to require certain patient protections for plans and utilization review agents to follow when establishing a step therapy protocol. SUMMARY OF PROVISIONS: Section one amends section 4902 of the insurance law by adding two new paragraphs (14) and (15) that require a utilization review agent, when they are establishing a step therapy protocol, to ensure various proto- cols. These include prohibiting a prescription drug that has not been approved by the US FDA from being within a step therapy protocol. In
S8191 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8191 I N S E N A T E February 1, 2022 ___________ Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law and the public health law, in relation to requiring a utilization review agent to follow certain rules when establishing a step therapy protocol THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (a) of section 4902 of the insurance law is amended by adding two new paragraphs 14 and 15 to read as follows: (14) WHEN ESTABLISHING A STEP THERAPY PROTOCOL, A UTILIZATION REVIEW AGENT SHALL ENSURE THAT THE PROTOCOL CANNOT: (I) REQUIRE A PRESCRIPTION DRUG THAT HAS NOT BEEN APPROVED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION FOR THE MEDICAL CONDITION BEING TREATED; (II) REQUIRE AN INSURED TO TRY AND FAIL ON MORE THAN ONE DRUG BEFORE PROVIDING COVERAGE TO THE INSURED FOR THE PRESCRIBED DRUG; (III) REQUIRE THE USE OF A STEP THERAPY-REQUIRED DRUG FOR LONGER THAN THIRTY DAYS; (IV) BE IMPOSED ON AN INSURED IF THE INSURED HAS TAKEN THE PRESCRIBED DRUG COVERED BY THE PLAN WITHIN THE PAST THREE HUNDRED SIXTY-FIVE DAYS; (V) REQUIRE A NEWLY ENROLLED INSURED TO REPEAT STEP THERAPY FOR A PRESCRIBED DRUG WHERE THAT INSURED ALREADY COMPLETED STEP THERAPY FOR THAT DRUG UNDER A PRIOR PLAN; AND (VI) BE IMPOSED ON AN INSURED FOR A PRESCRIBED DRUG THAT WAS PREVIOUS- LY APPROVED FOR COVERAGE BY A PLAN FOR A SPECIFIC MEDICAL CONDITION AFTER THE INSURED'S PLAN IMPLEMENTS A FORMULARY CHANGE THAT IMPACTS THE FORMULARY STATUS OF THE PRESCRIBED DRUG. (15) WHEN ESTABLISHING A STEP THERAPY PROTOCOL, A UTILIZATION REVIEW AGENT SHALL ENSURE THAT THE PROTOCOL ACCEPTS ANY ATTESTATION SUBMITTED BY THE INSURED'S HEALTH CARE PROFESSIONAL AS DEFINED IN SECTION FOUR THOUSAND NINE HUNDRED OF THIS TITLE STATING THAT A REQUIRED DRUG HAS FAILED AS PRIMA FACIE EVIDENCE THAT THE REQUIRED DRUG HAS FAILED. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD14433-01-2 S. 8191 2
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.